Valiant Laboratories Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Low debt relative to equity (D/E 0.2x)
Concerns
- Currently loss-making (EPS ₹-0.5)
- Negative return on equity (ROE -1.2%)
- Low capital efficiency (ROCE 0.8%)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,758 | ₹4.2L Cr | 33.2 | 5.05 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,559 | ₹2.4L Cr | 79.8 | 15.15 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,557 | ₹1.7L Cr | 79.3 | 9.43 | 27.4 | 15.2 | 0.77 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,176 | ₹1.1L Cr | 23.1 | 4.37 | 21.2 | 21.1 | 0.38 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,137 | ₹1.1L Cr | 52.8 | 12.35 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,366 | ₹1.1L Cr | 30.2 | 3.21 | 11.6 | 15.5 | 0.01 |
| LAURUSLABS Laurus Labs Limited | ₹2,182 | ₹1.1L Cr | 97.4 | 22.22 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
VALIANTLAB · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 74.94% | 74.94% | 74.94% | 74.94% | 74.94% | 74.94% |
| FII | 7.08% | 3.48% | 1.89% | — | — | 0.64% |
| DII | 0.43% | — | — | — | — | — |
| Public | 17.54% | 21.58% | 23.18% | 25.06% | 25.06% | 24.42% |
Latest News
All newsValiant Labs invests in AMPYR Renewable Energy firm
*Valiant Labs invests in AMPYR Renewable Energy Resources.* The move marks a strategic entry into the renewable energy space, signaling diversification beyond its core pharma business. Financial terms including the investment amount of **₹** were not disclosed. This could influence investor sentiment positively. 📊 *STOCKS:* $VALIANTLAB | 🏢 *SECTOR:* Corporate | #MEDIUMIMPACT #Investment
Valiant Laboratories to hold 5th AGM, details published
*Valiant Laboratories to hold 5th AGM, details published.* The company has released a newspaper publication notifying shareholders about its upcoming Annual General Meeting. No financial figures or strategic updates were disclosed. The event is part of routine corporate compliance. 📊 *STOCKS:* VALIANTLAB | 🏢 *SECTOR:* Pharma | #LOWIMPACT #AGM